Results 231 to 240 of about 6,253,748 (354)
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Analysis of Thick-Walled Oxygen-Free Copper Pipe Production in the Bridge Die Extrusion Process. [PDF]
Materials (Basel)Knapiński M +4 more
europepmc +1 more source
New Material Studies in the Cornell Sample Host Cavity
, 2016 James Maniscalco +5 more
openalex +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
Molecular Oncology, EarlyView.This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Compact THz absorption spectroscopy using a LiNbO<sub>3</sub> slot waveguide. [PDF]
Light Sci ApplSung ER, Nelson KA.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Molecular Oncology, EarlyView.Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Investigating microstructural and mechanical properties evolution in biomedical AZ31 magnesium alloy under different casting conditions. [PDF]
Sci RepDhanuskar G +4 more
europepmc +1 more source